QQ客服 官方微博 反馈留言

	Antisense hypoxia-inducible factor 1 alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma
	Liu, Fengjun; Wang, Peijun; Jiang, Xian; Tan, Gang; Qiao, Haiquan; Jiang, Hongchi; Krissansen, Geoffrey W.; Sun, Xueying
刊名	CANCER SCIENCE
	2008
卷号	99期号:10页码:2055-2061
DOI	10.1111/j.1349-7006.2008.00905.x
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5546019
专题	山东大学
作者单位	1.Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan 250012, Peoples R China. 2.Harbin Med Coll, Dept Stomatol,
推荐引用方式 GB/T 7714	Liu, Fengjun,Wang, Peijun,Jiang, Xian,et al. Antisense hypoxia-inducible factor 1 alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma[J]. CANCER SCIENCE,2008,99(10):2055-2061.
APA	Liu, Fengjun.,Wang, Peijun.,Jiang, Xian.,Tan, Gang.,Qiao, Haiquan.,...&Sun, Xueying.(2008).Antisense hypoxia-inducible factor 1 alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.CANCER SCIENCE,99(10),2055-2061.
MLA	Liu, Fengjun,et al."Antisense hypoxia-inducible factor 1 alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma".CANCER SCIENCE 99.10(2008):2055-2061.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。